We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
444% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $4.14M
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
44% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 41
21% more capital invested
Capital invested by funds: $352M → $426M (+$73.4M)
9% more funds holding
Funds holding: 136 → 148 (+12)
7.35% more ownership
Funds ownership: 87.8% → 95.15% (+7.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
148
Holders Change
+12
Holders Change %
+8.82%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
59
Reduced
41
Closed
9
Calls
$22.5M
Puts
$4.14M
Net Calls
+$18.4M
Net Calls Change
+$6.78M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.8M |
| 2 |
Two Sigma Advisers
New York
|
+$7.35M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.38M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$5.1M |
| 5 |
Two Sigma Investments
New York
|
+$4.71M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$6.75M |
| 2 |
ACM
Altium Capital Management
New York
|
-$3.45M |
| 3 |
JP Morgan Chase
New York
|
-$3.29M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.42M |
